Allovir, Inc.
ALVR
Revenue
165.00k
▲165.00k∞%
-Assets
130.99M
▼-13.16M▼-9.13%
3 Months ChangeLiabilities
10.70M
▼-13.01M▼-54.88%
3 Months ChangeFree Cash Flow
-19.00M
▼-19.00M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0000950170-24-094380
2024-07-02
Form 8-K
ID: 0001193125-24-174335
2024-06-11
Form 8-K
ID: 0001193125-24-159226
2024-06-07
Form 8-K
ID: 0001193125-24-157311
2024-06-03
Form 8-K
ID: 0001193125-24-153013
2024-05-13
Form 10-Q
ID: 0000950170-24-058607
2024-02-12
Form 8-K
ID: 0001193125-24-032160
2024-01-04
Form 8-K
ID: 0001193125-24-002563
2023-12-22
Form 8-K
ID: 0001193125-23-301777
2023-11-02
Form 10-Q
ID: 0000950170-23-058145